Menu
GeneBe

20-43700043-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_002466.4(MYBL2):​c.950C>T​(p.Ser317Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000471 in 1,613,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

MYBL2
NM_002466.4 missense, splice_region

Scores

1
8
8
Splicing: ADA: 0.9955
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.52
Variant links:
Genes affected
MYBL2 (HGNC:7548): (MYB proto-oncogene like 2) The protein encoded by this gene, a member of the MYB family of transcription factor genes, is a nuclear protein involved in cell cycle progression. The encoded protein is phosphorylated by cyclin A/cyclin-dependent kinase 2 during the S-phase of the cell cycle and possesses both activator and repressor activities. It has been shown to activate the cell division cycle 2, cyclin D1, and insulin-like growth factor-binding protein 5 genes. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High AC in GnomAd4 at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYBL2NM_002466.4 linkuse as main transcriptc.950C>T p.Ser317Leu missense_variant, splice_region_variant 7/14 ENST00000217026.5
MYBL2NM_001278610.2 linkuse as main transcriptc.878C>T p.Ser293Leu missense_variant, splice_region_variant 6/13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYBL2ENST00000217026.5 linkuse as main transcriptc.950C>T p.Ser317Leu missense_variant, splice_region_variant 7/141 NM_002466.4 P1P10244-1
MYBL2ENST00000396863.8 linkuse as main transcriptc.878C>T p.Ser293Leu missense_variant, splice_region_variant 6/132 P10244-2

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152170
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000140
AC:
35
AN:
249510
Hom.:
0
AF XY:
0.000133
AC XY:
18
AN XY:
135026
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00142
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000178
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000445
AC:
65
AN:
1460812
Hom.:
0
Cov.:
37
AF XY:
0.0000399
AC XY:
29
AN XY:
726662
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000806
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.0000189
Gnomad4 NFE exome
AF:
0.0000108
Gnomad4 OTH exome
AF:
0.0000828
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152288
Hom.:
0
Cov.:
33
AF XY:
0.0000671
AC XY:
5
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000772
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000903
Hom.:
0
Bravo
AF:
0.000128
ExAC
AF:
0.000132
AC:
16

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 13, 2021The c.950C>T (p.S317L) alteration is located in exon 7 (coding exon 7) of the MYBL2 gene. This alteration results from a C to T substitution at nucleotide position 950, causing the serine (S) at amino acid position 317 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.19
CADD
Pathogenic
32
DANN
Pathogenic
1.0
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-3.3
D;D
REVEL
Benign
0.15
Sift
Uncertain
0.0090
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
1.0
.;D
Vest4
0.81
MVP
0.30
MPC
0.66
ClinPred
0.17
T
GERP RS
4.9
Varity_R
0.24
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.86
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs191011542; hg19: chr20-42328683; API